プロモーションスケジュール Shanghai Pharmaceuticals Holding Co., Ltd
詳細なスケジュール
簡易グラフ
会社について
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. さらに詳しくEBITDA | 75.53 |
---|---|
EV/EBITDA | 2.04 |
Industry | Health Care Providers & Services |
P/BV | 0.1122 |
P/E | 1.36 |
P/S | 0.0297 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Выручка | 1303.29 |
Див.доход ао | 5.78 |
Дивиденд ао | 0.4089 |
Сайт | https://www.sphchina.com |
Цена ао | 1.49 |
Число акций ао | 3.70129 млрд |
1日あたりの価格変動: | 0% (1.64) |
---|---|
週ごとの価格変動: | -2.67% (1.685) |
月ごとの料金変更: | -9.89% (1.82) |
3ヶ月間の価格変動: | +0.6135% (1.63) |
半年間の価格変動: | +13.73% (1.442) |
年間の価格変動: | +5.81% (1.55) |
3年間の価格推移: | +4.46% (1.57) |
5年間の価格推移: | 0% (1.64) |
10年間の価格推移: | 0% (1.64) |
年初からの価格変動: | +29.13% (1.27) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
配当, % | 配当 | 当期の実績を踏まえて | 前に購入する | レジストリの閉鎖日 | 支払い前 |
---|---|---|---|---|---|
0.67% | 0.01 | II кв. 2024 | 13.09.2024 | 17.09.2024 | 02.10.2024 |
5.39% | 0.08 | II кв. 2023 | 14.07.2023 | 18.07.2023 | 02.08.2023 |
機関 | 音量 | 共有, % |
---|---|---|
Vanguard International Stock Index-Emerging Markets Stk | 12146926 | 1.32 |
Vanguard International Stock Index-Total Intl Stock Indx | 11883576 | 1.29 |
iShares Core MSCI Emerging Markets ETF | 7102300 | 0.77 |
Brandes Emerging Markets Value Fund | 5203000 | 0.57 |
DFA Emerging Markets Core Equity Portfolio | 4172100 | 0.45 |
iShares MSCI Emerging Markets Minimum Volatility Factor ETF | 3566400 | 0.39 |
DFA Investment Dimensions-DFA Emerging Mkts Value | 3299900 | 0.36 |
iShares ESG Aware MSCI EM ETF | 3014100 | 0.33 |
iShares MSCI China ETF | 2093800 | 0.23 |
iShares MSCI Emerging Markets ETF | 1923800 | 0.21 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Mr. Bo Shen | President, CFO, Head of the Accounting Department & Executive Director | 804.26k | 1973 (52 年) |
Mr. Yongzhong Li | VP & Executive Director | 904.39k | 1970 (55 年) |
Mr. Tao Zhong | VP, Board Secretary & Joint Company Secretary | N/A | 1972 (53 年) |
Mr. Dongming Li | Vice President | N/A | 1969 (56 年) |
Ms. Shuai Shao | Vice President | N/A | 1988 (37 年) |
Dr. Shunjiang Yu | Chief Medical Officer | N/A | |
Mr. Ming Dong | Executive Director | N/A | 1976 (49 年) |
Ying Ke | Director & General Manager of R&D Management Center | N/A | |
Mr. Qiuhua Yang | Executive Chairman | N/A | 1972 (53 年) |
Ms. Pui Kiu Wong | Joint Company Secretary | N/A |
住所: China, Shanghai, Shanghai Pharmaceutical Building - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.sphchina.com
Webサイト: https://www.sphchina.com